Alendronate Sodium
阿仑膦酸钠
Report date: 2026/04/14 20:00:15
NME
Base Information
Drug NameAlendronate Sodium
Drug Alias Name +[30]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[20]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1993/01/01
Country/Territory +[21]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesEffRx Pharmaceuticals SAThe University Of California DavisMerck Sharp & Dohme Corp +[8]
Inactive CompaniesEvangelisches Krankenhaus Lutherhaus GgmbhEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentChinese University Of Hong Kong (Cuhk) +[25]
Active Indications +[8]
Inactive Indications +[12]